Mechanisms of disease: Molecular pathogenesis of cholestasis

New England Journal of Medicine

Volumn 339, Issue 17, 1998, Pages 1217-1227

  Trauner, Michael ^a   Meier, Peter J ^b   Boyer, James L ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; BILE SALT; CARRIER PROTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; URSODEOXYCHOLIC ACID;

BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; BILE SECRETION; CHOLESTASIS; CYTOSKELETON; EPITHELIUM CELL; FAMILIAL DISEASE; GENE MUTATION; GENE THERAPY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CELL; MEMBRANE POTENTIAL; MEMBRANE TRANSPORT; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; ACTIVE TRANSPORT; ANIMAL; BILE; BILE DUCT; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; ION TRANSPORT; LIVER; METABOLISM; MUTATION; PATHOLOGY; SECRETION;

ANIMALS; BILE; BILE DUCTS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CHOLESTASIS; CYTOSKELETON; GENE EXPRESSION REGULATION; HUMANS; ION PUMPS; LIVER; MUTATION; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 0032558588     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199810223391707     Document Type: Review

References (95)

1. Reichen J, Simon FR. Cholestasis. In: Arias IM, ed. The liver: biology and pathobiology. 3rd ed. New York: Raven Press, 1994:1291-326.
2. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991;14:551-66.
3. Boyer JL. Bile duct epithelium: frontiers in transport physiology. Am J Physiol 1996;270:G1-G5.
4. Hagenbuch B, Meier PJ. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin Liver Dis 1996;16:129-36.
5. Idem. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 1994;93:1326-31.
6. Kullak-Ublick GA, Hagenbuch B, Stieger B, et al. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995;109:1274-82.
7. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987; 84:7735-8.
8. Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 1989;264:11693-8.
9. Elferink RPJ, Tytgat GNJ, Groen AK. Hepatic canalicular membrane 1: the role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J 1997;11:19-28.
10. Paulusma CC, Bosma PJ, Zaman GJR, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996;271:1126-8.
11. Buchler M, Konig J, Brom M, et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-8.
12. Keppler D, Konig J. Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2(cMRP/ cMOAT) gene in liver. FASEB J 1997;11:509-16.
13. Sippel CJ, McCollum MJ, Perlmutter DH. Bile acid transport by the rat liver canalicular bile acid transport/ecto-ATPase protein is dependent on ATP but not on its own ecto-ATPase activity. J Biol Chem 1994;269: 2820-6.
14. Ortiz DF, St Pierre MV, Abdulmessih A, Arias IM. A yeast ATP-binding cassette-type protein mediating ATP-dependent bile acid transport. J Biol Chem 1997;272:15358-65.
15. Gerloff T, Stieger B, Hagenbuch B, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998;273:10046-50.
16. Childs S, Yeh RL, Georges E, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res 1995;55:2029-34.
17. Che M, Gatmaitan Z, Arias IM. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. FASEB J 1997;11:101-8.
18. Phillips MJ, Poucell S, Oda M. Mechanisms of cholestasis. Lab Invest 1986;54:593-608.
19. Strazzabosco M, Boyer JL. Regulation of intracellular pH in the hepatocyte: mechanisms and physiological implications. J Hepatol 1996;24: 631-44.
20. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieto J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994;19:1400-6.
21. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993;105:1857-64.
22. Moseley RH. Sepsis-associated cholestasis. Gastroenterology 1997; 112:302-6.
23. Bossard R, Stieger B, O'Neill B, Fricker G, Meier PJ. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest 1993;91:2714-20.
24. Gartung C, Ananthanarayanan M, Rahman MA, et al. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996;110:199-209.
25. Moseley RH, Wang W, Takeda H, et al. Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. Am J Physiol 1996;271:G137-G146.
26. Simon FR, Fortune J, Iwahashi M, Gartung C, Wolkoff A, Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996;271:G1043-G1052.
27. Bolder U, Ton-Nu HT, Schteingart CD, Frick E, Hofmann AF. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. Gastroenterology 1997;112:214-25.
28. Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995;4: 1049-53.
29. Bull LN, van Eijk MJT, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-24.
30. Strautnieks SS, Kagalwalla AF, Tanner MS, et al. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 1997;61:630-3.
31. Deleuze JF, Jacquemin E, Dubuisson C, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996;23:904-8.
32. de Vree JML, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998;95:282-7.
33. Houwen RHJ, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380-6.
34. Shneider BL, Fox VL, Schwarz KB, et al. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology 1997;25:1176-83.
35. Kullak-Ublick G, Beuers U, Fahney C, Hagenbuch B, Meier PJ, Paumgartner G. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology 1997;26:991-7.
36. Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993;105:572-8.
37. Medina JF, Martinez-Anso E, Vazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997;25:12-7.
38. Nozawa S, Miyazaki M, Itou H, et al. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice. Gastroenterology 1997;112:Suppl:A1349. abstract.
39. Bull LN, Carlton VEH, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997;26:155-64.
40. Sela-Herman S, Bull L, Lomri N, et al. In search of a gene for hereditary cholestasis. Biochem Mol Med 1996;59:98-103.
41. Dumoulin FL, Reichel C, Sauerbruch T, Spengler U. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol 1997;26:852-6.
42. Kadmon M, Klünemann C, Böhme M, et al. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology 1993;104:1507-14.
43. Bohme M, Muller M, Leier I, Jedlitschky G, Keppler D. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994;107:255-65.
44. Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996;23:1061-6.
45. Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-42.
46. Oude Elferink RPJ, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim Biophys Acta 1995; 1241:215-68.
47. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. In: Boyer JL, Ockner RK, eds. Progress in liver diseases. Vol. 14. Philadelphia: W.B. Saunders, 1996:55-67.
48. Chojkier M. Regulation of liver-specific gene expression. In: Boyer JL, Ockner RK, eds. Progress in liver diseases. Vol. 13. Philadelphia: W.B. Saunders, 1995:37-61.
49. Karpen SJ, Sun AQ, Kudish B, et al. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem 1996;271:15211-21.
50. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin down-regulates hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 1998;101:2092-100.
51. Müller M, Vos TA, Koopen NR, Roelofsen H, Kuipers F, Jansen PLM. Localization and regulation of a novel canalicular ABC-transporter. Hepatology 1996;24:Suppl:368A. abstract.
52. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255-64.
53. Vazquez JJ, Vazquez M, Idoate MA, et al. Anion exchanger immuno-reactivity in human salivary glands in health and Sjogren's syndrome. Am J Pathol 1995;146:1422-32.
54. +/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion. Hepatology 1997;25:284-90.
55. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993;17:854-60.
56. Preisegger K-H, Stumptner C, Riegelnegg D, et al. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Hepatology 1996;24:248-52.
57. Green RM, Beier D, Gollan JL. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 1996;111:193-8.
58. +-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol 1997;27:1051-6.
59. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
60. Colombo C, Battezzati PM, Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis 1994;14:259-69.
61. Anderson JM. Leaky junctions and cholestasis: a tight correlation. Gastroenterology 1996;110:1662-5.
62. Weber AM, Tuchweber B, Yousef I, et al. Severe familial cholestasis in North American Indian children: a clinical model of microfilament dysfunction. Gastroenterology 1981;81:653-62.
63. Rahner C, Stieger B, Landmann L. Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver. Gastroenterology 1996;110:1564-78.
64. Anderson JM, Glade JL, Stevenson BR, Boyer JL, Mooseker MS. Hepatic immunohistochemical localization of the tight junction protein ZO-1 in rat models of cholestasis. Am J Pathol 1989;134:1055-62.
65. Fallon MB, Mennone A, Anderson JM. Altered expression and localization of the tight junction protein ZO-1 after common bile duct ligation. Am J Physiol 1993;264:C1439-C1447.
66. Fallon MB, Brecher AR, Balda MS, Matter K, Anderson JM. Altered hepatic localization and expression of occludin after common bile duct ligation. Am J Physiol 1995;269:C1057-C1062.
67. Barr VA, Hubbard AL. Newly synthesized hepatocyte plasma membrane proteins are transported in transcytotic vesicles in the bile duct-ligated rat. Gastroenterology 1993;105:554-71.
68. Stieger B, Landmann L. Effects of cholestasis on membrane flow and surface polarity in hepatocytes. J Hepatol 1996;24:Suppl 1:128-34.
69. Stieger B, Meier PJ, Landmann L. Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells. Hepatology 1994;20:201-12. [Erratum, Hepatology 1994;20:772.]
70. Jones AL, Schmucker DL, Mooney JS, Adler RD, Ockner RK. Morphometric analysis of rat hepatocytes after total biliary obstruction. Gastroenterology 1976;71:1050-60.
71. Larkin JM, Palade GE. Transcytotic vesicular carriers for polymeric IgA receptors accumulate in rat hepatocytes after bile duct ligation. J Cell Sci 1991;98:205-16.
72. Marks DL, LaRusso NF, McNiven MA. Isolation of the microtubulevesicle motor kinesin from rat liver: selective inhibition by cholestatic bile acids. Gastroenterology 1995;108:824-33.
73. Boyer JL, Soroka CJ. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology 1995;109:1600-11.
74. Beuers U, Nathanson MH, Isales CM, Boyer JL. Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. J Clin Invest 1993;92:2984-93.
75. Fallon MB, Nathanson MH, Mennone A, Saez JC, Burgstahler AD, Anderson JM. Altered expression and function of hepatocyte gap junctions after common bile duct ligation in the rat. Am J Physiol 1995;268:C1186-C1194.
76. Nathanson MH, Schlosser SF. Calcium signaling mechanisms in liver in health and disease. In: Boyer JL, Ockner RK, eds. Progress in liver disease. Vol. 14. Philadelphia: W.B. Saunders, 1996:1-27.
77. Dixon BS, Sutherland E, Alexander A, Nibel D, Simon FR. Distribution of adenylate cyclase and GTP-binding proteins in hepatic plasma membranes. Am J Physiol 1993;265:G686-G698.
78. Rodriguez-Henche N, Guijarro LG, Couvineau A, et al. G proteins in rat liver proliferation during cholestasis. Hepatology 1994;20:1041-7.
79. Alpini G, Ulrich CD II, Phillips JO, Pham LD, Miller LJ, LaRusso NF. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994;266:G922-G928.
80. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113: 884-90.
81. Poupon R, Poupon RE. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children. Pharmacol Ther 1995;66:1-15.
82. Lindor KD. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997;336:691-5.
83. Setchell KDR, Rodrigues CMP, Clerici C, et al. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology 1997;112:226-35.
84. Guldutuna S, Zimmer G, Imhof M, Bhatti S, You TG, Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology 1993;104:1736-44.
85. Van Nieuwkerk CMJ, Elferink RPJ, Groen AK, et al. Effects of ursodeoxycholate and cholate feeding on liver diseases in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996;111:165-71.
86. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990;11:12-5.
87. Yoshikawa M, Tsujii T, Matsumura K, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992;16: 358-64.
88. Hillaire S, Boucher E, Calmus Y, et al. Effects of bile acids and cholestasis on major histocompatibility complex class I in human and rat hepatocytes. Gastroenterology 1994;107:781-8.
89. Beuers U, Nathanson MH, Boyer JL. Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes. Gastroenterology 1993;104:604-12.
90. Beuers U, Throckmorton DC, Anderson MS, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 1996;110:1553-63.
91. Jazrawi RP, de Caestecker JS, Goggin PM, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106:134-42.
92. - currents in a biliary cell line. Gastroenterology 1995;109:965-72.
93. Yang Y, Raper SE, Cohn JA, Engelhardt JF, Wilson JM. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci U S A 1993;90:4601-5.
94. Grubman SA, Fang SL, Mulberg AE, et al. Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines. Gastroenterology 1995;108:584-92.
95. Chang AGY, Wu GY. Gene therapy: applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994;106:1076-84.